Skip to main content

Table 1 Characteristics of participants in the NHANES (2007–2016) by Klotho levels

From: A cohort study on the correlation between serum Klotho levels and all-cause mortality in American diabetic populations

 

Klotho levels

 

Variables

Q1

Q2

Q3

Q4

P-value

Participants, No.

890

890

890

890

 

Klotho(pg/ml)

525.9(87.7)

723.5(44.8)

897.4(57.6)

1290.7(331.4)

< 0.001

Clinical parameters

     

Age(years)

62.8(10.0)

61.8(10.1)

61.1(9.9)

59.8(10.0)

< 0.001

Gender, n (%)

    

0.272

 Female

424 (47.6)

416 (46.7)

452 (50.8)

445 (50.0)

 

 Male

466 (52.4)

474 (53.3)

438 (49.2)

445 (50.0)

 

Race, n (%)

    

< 0.001

 Mexican American

184 (20.7)

170 (19.1)

195 (21.9)

178 (20.0)

 

 Non-Hispanic Black

217 (24.4)

187 (21.0)

173 (19.4)

253 (28.4)

 

 Non-Hispanic White

322 (36.2)

327 (36.7)

305 (34.3)

253 (28.4)

 

 Other Hispanic

92 (10.3)

119 (13.4)

119 (13.4)

134 (15.1)

 

 Other Race

75 (8.4)

87 (9.8)

98 (11.0)

72 (8.1)

 

PIR

2.2 (1.5)

2.3 (1.5)

2.2 (1.5)

2.3 (1.6)

0.970

Marital status, n (%)

    

0.971

 Divorced/ Separated

186 (20.9)

181 (20.3)

184 (20.7)

173 (19.4)

 

 Married/ Living with partner

547 (61.5)

555 (62.4)

547 (61.5)

549 (61.7)

 

 Never married/ Widowed

157 (17.6)

154 (17.3)

159 (17.9)

168 (18.9)

 

Smoking, n (%)

    

0.003

 Never smoker

405 (45.5)

393 (44.1)

467 (52.5)

457 (51.3)

 

 Former smoker

321 (36.1)

337 (37.9)

282 (31.7)

278 (31.2)

 

 Current smoker

164 (18.4)

160 (18.0)

141 (15.8)

155 (17.5)

 

Alcohol status, n (%)

    

0.566

 Never

148 (16.6)

163 (18.3)

179 (20.1)

163 (18.3)

 

 Former

278 (31.2)

260 (29.2)

247 (27.8)

260 (29.2)

 

 Current

464 (52.2)

467 (52.5)

464 (52.1)

467 (52.5)

 

Vital signs

     

BMI (kg/m2)

32.5 (7.0)

32.6 (7.2)

32.5 (7.4)

32.4(7.5)

0.984

DBP (mmHg)

67.6 (12.9)

68.7(13.1)

69.6(12.8)

70.8(12.9)

< 0.001

SBP (mmHg)

130.8(19.9)

130.4(18.8)

129.3(18.4)

131.0(19.3)

0.261

Laboratory parameters

    

 ALT(U/L)

24.5(14.0)

25.7(13.7)

28.2(33.4)

31.4 (25.7)

< 0.001

 Alb(g/L)

41.3 (3.5)

41.8(3.2)

41.8(3.3)

41.4(3.5)

< 0.001

 Creatinine(umol/L)

106.1(99.0)

86.1(40.6)

81.8(53.2)

80.0 (43.6)

< 0.001

 eGFR (mL/min/1.73m2)

75.1(27.0)

83.0(24.7)

86.6(22.1)

89.5(23.3)

< 0.001

 TC (mg/dl)

4.7 (1.2)

4.8 (1.2)

4.9(1.1)

5.0 (1.3)

< 0.001

 HDL (mmol/L)

1.3 (0.4)

1.2 (0.4)

1.2 (0.4)

1.2 (0.4)

0.561

 HbA1c (%)

6.9 (1.3)

7.1(1.6)

7.2(1.7)

7.7 (2.1)

< 0.001

Comorbidities

     

 Hyperlipidemia, n (%)

   

0.223

 No

90 (10.1)

96 (10.8)

109 (12.2)

115 (12.9)

 

 Yes

800 (89.9)

794 (89.2)

781 (87.8)

775 (87.1)

 

 Stroke, n (%)

    

0.057

 No

795 (89.3)

823 (92.5)

822 (92.4)

818 (91.9)

 

 Yes

95(10.7)

67 (7.5)

68 (7.6)

72 (8.1)

 

 Coronary heart disease, n (%)

   

0.007

 No

780 (87.6)

804 (90.3)

812 (91.2)

821 (92.2)

 

 Yes

110 (12.4)

86 (9.7)

78 (8.8)

69 (7.8)

 

 Hypertension, n (%)

    

0.024

 No

204 (22.9)

229 (25.7)

249 (28.0)

256 (28.8)

 

 Yes

686 (77.1)

661 (74.3)

641 (72.0)

634 (71.2)

 
  1. Abbreviations: PIR, poverty income ratio; BMI, body mass index; DBP, diastolic pressure; SBP, systolic pressure; ALT, alanine transaminase; Alb, albumin; eGFR, estimated glomerular filtration rate; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; HbA1c, glycohemoglobin